Bare -Metal Stents and Drug -Eluting Stents in the Treatment of Patients With Vertebral Artery Ostium Stenosis
A Prospectie Cohort Study of Bare -Metal Stents and Drug -Eluting Stents in the Treatment of Patients With Vertebral Artery Ostium Stenosis
1 other identifier
observational
168
1 country
1
Brief Summary
The study hypothesizes that Drug -eluting stents are more effective in preventing restenosis than Bare-metal stents after Vertebral Artery Ostium stenting
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
July 21, 2014
CompletedFirst Posted
Study publicly available on registry
July 22, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedOctober 24, 2016
July 1, 2014
1.4 years
July 21, 2014
October 21, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Late loss in lumen diameter in follow-up ≥50%
Late loss in lumen diameter in follow-up ≥50%
1 year
Death, non -fatal stroke 30 days after stent implantation associated with antiplatelet drugs
Death, non -fatal stroke 30 days after stent implantation associated with antiplatelet drugs
30 days
Death, non -fatal stroke 12 months after stent implantation associated with antiplatelet drugs
Death, non -fatal stroke 12 months after stent implantation associated with antiplatelet drugs
12 months
Secondary Outcomes (1)
brain, gastrointestinal and urinary system bleeding in 12 months follow-up
12 months
Study Arms (1)
BMS group, DES group
All the participants in this group will be performed with bare-metal stents or drug -eluting stents
Interventions
all the participants in this group will be performed with drug -eluting stents
all the participants in this group will be performed with bare-metal stents
Eligibility Criteria
Symptomatic status: as evidenced by TIA or non-severe stroke within the past 12 months attributed to 70% to 99% stenosis of vertebral artery ostium are eligible. Degree of stenosis: \>70% and \<99%; stenosis may be diagnosed by TCD, MRA, or CTA to qualify for angiogram performed as part of the study protocol, but must be confirmed by catheter angiography for enrollment in the trial. All the patients should be performed with PTAS beyond a duration of 3 weeks from the latest ischemic symptom onset. No fresh infarctions identified on MRI (indicated as high signals on DWI series) upon enrollment.Patient is willing and able to return for all follow-up visits required by the protocol Patient understands the purpose and requirements of the study, can make him/herself understood, and has signed informed consent.
You may qualify if:
- \- symptomatic posterior circulation ischemia including monor stroke (mRS ≤2) or TIA result from the stenosis in the vertebral artery ostium.
- % to 99% stenosis of vertebral artery ostium.
You may not qualify if:
- etiology of stenotic lesions not atherosclerosis patients had undergone previos interventions on the vertebral artery ostium ipsilateral severe stenotic lesions in subclavian artery involved as well as vertebral artery ostium
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of neurosurgery, Xuanwu hospital
Beijing, 100053, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Feng Ling, M.D.
Xuanwu Hospital, Capital University of Medical Sciences, Beijing, China
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 21, 2014
First Posted
July 22, 2014
Study Start
January 1, 2014
Primary Completion
June 1, 2015
Study Completion
June 1, 2016
Last Updated
October 24, 2016
Record last verified: 2014-07